CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USING THE SAME
To provide compositions for treating Parkinson's disease and associated conditions.SOLUTION: Pharmaceutical combinations and compositions comprise a carbidopa prodrug such as formula (I-a) and an L-dopa prodrug such as formula (II-a).SELECTED DRAWING: None 【課題】パーキンソン病および関連状態の治療するための組成物の提供。【解決手段...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JAMES STAMBULI MILLER CHRISTOPHER P LAO YANBIN LOU XIAOCHUN PETER T MAYER JII WAN VINCENT S CHAN SEAN E MACKEY VALENTINO J STELLA HUANG YE ALEXANDER D HUTERS BRIAN P ENRIGHT PHILIP R KYM KASSIBLA E DEMPAH ERIC A VOIGHT MATULENKO MARK A GEOFF G ZHANG RUSSELL C KLIX BENOIT CARDINAL-DAVID RODGER F HENRY RAIMUNDO HO SCOTT W KRABBE |
| description | To provide compositions for treating Parkinson's disease and associated conditions.SOLUTION: Pharmaceutical combinations and compositions comprise a carbidopa prodrug such as formula (I-a) and an L-dopa prodrug such as formula (II-a).SELECTED DRAWING: None
【課題】パーキンソン病および関連状態の治療するための組成物の提供。【解決手段】式（I-a)等のカルビドパプロドラッグと式（II-a)等のＬ－ドーパプロドラッグを含む医薬組み合わせ及び組成物。TIFF2023174770000165.tif75164【選択図】なし |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2023174770A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2023174770A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2023174770A3</originalsourceid><addsrcrecordid>eNrjZLB2dgxy8nTxD3BUcPRzUfDRBTMDgvxdgkLdg8Fivq4hHv4uwQr-bgqhwZ5-7gohHq4KwY6-rjwMrGmJOcWpvFCam0HJzTXE2UM3tSA_PrW4IDE5NS-1JN4rwMjAyNjQ3MTc3MDRmChFAOo7KSw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USING THE SAME</title><source>esp@cenet</source><creator>JAMES STAMBULI ; MILLER CHRISTOPHER P ; LAO YANBIN ; LOU XIAOCHUN ; PETER T MAYER ; JII WAN ; VINCENT S CHAN ; SEAN E MACKEY ; VALENTINO J STELLA ; HUANG YE ; ALEXANDER D HUTERS ; BRIAN P ENRIGHT ; PHILIP R KYM ; KASSIBLA E DEMPAH ; ERIC A VOIGHT ; MATULENKO MARK A ; GEOFF G ZHANG ; RUSSELL C KLIX ; BENOIT CARDINAL-DAVID ; RODGER F HENRY ; RAIMUNDO HO ; SCOTT W KRABBE</creator><creatorcontrib>JAMES STAMBULI ; MILLER CHRISTOPHER P ; LAO YANBIN ; LOU XIAOCHUN ; PETER T MAYER ; JII WAN ; VINCENT S CHAN ; SEAN E MACKEY ; VALENTINO J STELLA ; HUANG YE ; ALEXANDER D HUTERS ; BRIAN P ENRIGHT ; PHILIP R KYM ; KASSIBLA E DEMPAH ; ERIC A VOIGHT ; MATULENKO MARK A ; GEOFF G ZHANG ; RUSSELL C KLIX ; BENOIT CARDINAL-DAVID ; RODGER F HENRY ; RAIMUNDO HO ; SCOTT W KRABBE</creatorcontrib><description>To provide compositions for treating Parkinson's disease and associated conditions.SOLUTION: Pharmaceutical combinations and compositions comprise a carbidopa prodrug such as formula (I-a) and an L-dopa prodrug such as formula (II-a).SELECTED DRAWING: None
【課題】パーキンソン病および関連状態の治療するための組成物の提供。【解決手段】式（I-a)等のカルビドパプロドラッグと式（II-a)等のＬ－ドーパプロドラッグを含む医薬組み合わせ及び組成物。TIFF2023174770000165.tif75164【選択図】なし</description><language>eng ; jpn</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231208&DB=EPODOC&CC=JP&NR=2023174770A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231208&DB=EPODOC&CC=JP&NR=2023174770A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JAMES STAMBULI</creatorcontrib><creatorcontrib>MILLER CHRISTOPHER P</creatorcontrib><creatorcontrib>LAO YANBIN</creatorcontrib><creatorcontrib>LOU XIAOCHUN</creatorcontrib><creatorcontrib>PETER T MAYER</creatorcontrib><creatorcontrib>JII WAN</creatorcontrib><creatorcontrib>VINCENT S CHAN</creatorcontrib><creatorcontrib>SEAN E MACKEY</creatorcontrib><creatorcontrib>VALENTINO J STELLA</creatorcontrib><creatorcontrib>HUANG YE</creatorcontrib><creatorcontrib>ALEXANDER D HUTERS</creatorcontrib><creatorcontrib>BRIAN P ENRIGHT</creatorcontrib><creatorcontrib>PHILIP R KYM</creatorcontrib><creatorcontrib>KASSIBLA E DEMPAH</creatorcontrib><creatorcontrib>ERIC A VOIGHT</creatorcontrib><creatorcontrib>MATULENKO MARK A</creatorcontrib><creatorcontrib>GEOFF G ZHANG</creatorcontrib><creatorcontrib>RUSSELL C KLIX</creatorcontrib><creatorcontrib>BENOIT CARDINAL-DAVID</creatorcontrib><creatorcontrib>RODGER F HENRY</creatorcontrib><creatorcontrib>RAIMUNDO HO</creatorcontrib><creatorcontrib>SCOTT W KRABBE</creatorcontrib><title>CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USING THE SAME</title><description>To provide compositions for treating Parkinson's disease and associated conditions.SOLUTION: Pharmaceutical combinations and compositions comprise a carbidopa prodrug such as formula (I-a) and an L-dopa prodrug such as formula (II-a).SELECTED DRAWING: None
【課題】パーキンソン病および関連状態の治療するための組成物の提供。【解決手段】式（I-a)等のカルビドパプロドラッグと式（II-a)等のＬ－ドーパプロドラッグを含む医薬組み合わせ及び組成物。TIFF2023174770000165.tif75164【選択図】なし</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB2dgxy8nTxD3BUcPRzUfDRBTMDgvxdgkLdg8Fivq4hHv4uwQr-bgqhwZ5-7gohHq4KwY6-rjwMrGmJOcWpvFCam0HJzTXE2UM3tSA_PrW4IDE5NS-1JN4rwMjAyNjQ3MTc3MDRmChFAOo7KSw</recordid><startdate>20231208</startdate><enddate>20231208</enddate><creator>JAMES STAMBULI</creator><creator>MILLER CHRISTOPHER P</creator><creator>LAO YANBIN</creator><creator>LOU XIAOCHUN</creator><creator>PETER T MAYER</creator><creator>JII WAN</creator><creator>VINCENT S CHAN</creator><creator>SEAN E MACKEY</creator><creator>VALENTINO J STELLA</creator><creator>HUANG YE</creator><creator>ALEXANDER D HUTERS</creator><creator>BRIAN P ENRIGHT</creator><creator>PHILIP R KYM</creator><creator>KASSIBLA E DEMPAH</creator><creator>ERIC A VOIGHT</creator><creator>MATULENKO MARK A</creator><creator>GEOFF G ZHANG</creator><creator>RUSSELL C KLIX</creator><creator>BENOIT CARDINAL-DAVID</creator><creator>RODGER F HENRY</creator><creator>RAIMUNDO HO</creator><creator>SCOTT W KRABBE</creator><scope>EVB</scope></search><sort><creationdate>20231208</creationdate><title>CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USING THE SAME</title><author>JAMES STAMBULI ; MILLER CHRISTOPHER P ; LAO YANBIN ; LOU XIAOCHUN ; PETER T MAYER ; JII WAN ; VINCENT S CHAN ; SEAN E MACKEY ; VALENTINO J STELLA ; HUANG YE ; ALEXANDER D HUTERS ; BRIAN P ENRIGHT ; PHILIP R KYM ; KASSIBLA E DEMPAH ; ERIC A VOIGHT ; MATULENKO MARK A ; GEOFF G ZHANG ; RUSSELL C KLIX ; BENOIT CARDINAL-DAVID ; RODGER F HENRY ; RAIMUNDO HO ; SCOTT W KRABBE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2023174770A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2023</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JAMES STAMBULI</creatorcontrib><creatorcontrib>MILLER CHRISTOPHER P</creatorcontrib><creatorcontrib>LAO YANBIN</creatorcontrib><creatorcontrib>LOU XIAOCHUN</creatorcontrib><creatorcontrib>PETER T MAYER</creatorcontrib><creatorcontrib>JII WAN</creatorcontrib><creatorcontrib>VINCENT S CHAN</creatorcontrib><creatorcontrib>SEAN E MACKEY</creatorcontrib><creatorcontrib>VALENTINO J STELLA</creatorcontrib><creatorcontrib>HUANG YE</creatorcontrib><creatorcontrib>ALEXANDER D HUTERS</creatorcontrib><creatorcontrib>BRIAN P ENRIGHT</creatorcontrib><creatorcontrib>PHILIP R KYM</creatorcontrib><creatorcontrib>KASSIBLA E DEMPAH</creatorcontrib><creatorcontrib>ERIC A VOIGHT</creatorcontrib><creatorcontrib>MATULENKO MARK A</creatorcontrib><creatorcontrib>GEOFF G ZHANG</creatorcontrib><creatorcontrib>RUSSELL C KLIX</creatorcontrib><creatorcontrib>BENOIT CARDINAL-DAVID</creatorcontrib><creatorcontrib>RODGER F HENRY</creatorcontrib><creatorcontrib>RAIMUNDO HO</creatorcontrib><creatorcontrib>SCOTT W KRABBE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JAMES STAMBULI</au><au>MILLER CHRISTOPHER P</au><au>LAO YANBIN</au><au>LOU XIAOCHUN</au><au>PETER T MAYER</au><au>JII WAN</au><au>VINCENT S CHAN</au><au>SEAN E MACKEY</au><au>VALENTINO J STELLA</au><au>HUANG YE</au><au>ALEXANDER D HUTERS</au><au>BRIAN P ENRIGHT</au><au>PHILIP R KYM</au><au>KASSIBLA E DEMPAH</au><au>ERIC A VOIGHT</au><au>MATULENKO MARK A</au><au>GEOFF G ZHANG</au><au>RUSSELL C KLIX</au><au>BENOIT CARDINAL-DAVID</au><au>RODGER F HENRY</au><au>RAIMUNDO HO</au><au>SCOTT W KRABBE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USING THE SAME</title><date>2023-12-08</date><risdate>2023</risdate><abstract>To provide compositions for treating Parkinson's disease and associated conditions.SOLUTION: Pharmaceutical combinations and compositions comprise a carbidopa prodrug such as formula (I-a) and an L-dopa prodrug such as formula (II-a).SELECTED DRAWING: None
【課題】パーキンソン病および関連状態の治療するための組成物の提供。【解決手段】式（I-a)等のカルビドパプロドラッグと式（II-a)等のＬ－ドーパプロドラッグを含む医薬組み合わせ及び組成物。TIFF2023174770000165.tif75164【選択図】なし</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2023174770A |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USING THE SAME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A09%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JAMES%20STAMBULI&rft.date=2023-12-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2023174770A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |